TRxADE HEALTH Reports First Quarter Gross Margin of 69% and Q1 2023 Financial Results
15 mai 2023 16h15 HE
|
Trxade Health, Inc.
Continues Nationwide Expansion of Breakthrough Digital Healthcare Services IT Platform TAMPA, FL, May 15, 2023 (GLOBE NEWSWIRE) -- TRxADE HEALTH, INC. (NASDAQ: MEDS) (“TRxADE” or the “Company”), a...
Healthier Choices Management Corp. Reports First Quarter 2023 Financial Results
08 mai 2023 08h00 HE
|
Healthier Choices Management Corp
-First Quarter Record Sales of $13.6 Million, Up 169%, over Q1 2022 -First Quarter Record Gross Profit of $4.9M Up 149%, over Q1 2022 HOLLYWOOD, FL, May 08, 2023 (GLOBE NEWSWIRE) --...
MamaMancini’s Reports First Quarter 2022 Financial Results
14 juin 2021 16h05 HE
|
MamaMancini's Holdings, Inc.
Company Fortifies Balance Sheet with Record $1.4 Million in Cash Flow from Operations; Stable Pre-Tax Net Income of $0.9 million Sales Lower 5% Due to One-Time COVID Impact in CY2020; Sales Up...
Intellinetics, Inc. Reports First Quarter Results
17 mai 2021 08h30 HE
|
Intellinetics, Inc.
Revenues Increase 117%; Earnings per share of $0.27 COLUMBUS, OH, May 17, 2021 (GLOBE NEWSWIRE) -- Intellinetics, Inc. (OTCQB: INLX), a cloud-based document solutions provider, announced...
Vallon Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporate Update
13 mai 2021 09h15 HE
|
Vallon Pharmaceuticals Inc.
- Company remains on track to report pivotal data from lead program, ADAIR, in second half 2021 - Novel abuse-deterrent platform technology enables pipeline expansion opportunities across multiple...
Guardion Health Sciences Reports First Quarter 2020 Financial Results and Provides Corporate Update
14 mai 2020 07h00 HE
|
Guardion Health Sciences, Inc.
— 40% increase in medical foods revenue in the first quarter compared to the same period last year — Launch of immuno-supportive/antioxidant complex, acuMMUNE™ — Growing portfolio of synergistic...
Corbus Pharmaceuticals Reports First Quarter Financial Results and Corporate Updates
11 mai 2020 07h05 HE
|
Corbus Pharmaceuticals Holdings, Inc.
Topline results for lenabasum Phase 3 RESOLVE-1 study in systemic sclerosis remain on schedule for summer of 2020, followed by Phase 2b study data in cystic fibrosis Phase 1 trial of CRB-4001 remains...
Tecnoglass Reports First Quarter 2020 Results
08 mai 2020 07h00 HE
|
Tecnoglass Inc.
- Ends Quarter with Strong Liquidity Position And Financial Flexibility - - Reports Record Backlog of $545.6 million - - Provides COVID-19 Business Update - First Quarter...
Celsion Corporation Reports First Quarter 2019 Financial Results and Provides Business Update
15 mai 2019 08h00 HE
|
Celsion CORP
Company to Hold Conference Call on Wednesday, May 15, 2019 at 11:00 a.m. EDT LAWRENCEVILLE, N.J, May 15, 2019 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN), an oncology drug...